Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield
click to rate
Posted by Two BlokesFri at 5:45 PM -
Filed in Stock
-
1 view
If you wonder whether Abbott Laboratories NYSE: ABT is a good buy in Q2 2025, the answer is yes. The company's management, portfolio, cash flow, capital return, and pipeline are why.